Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Andras Heczey(Baylor College of Medicine), Xin Xu(Baylor College of Medicine), Amy N. Courtney(Baylor College of Medicine), Gengwen Tian(Baylor College of Medicine), Gabriel A. Barragán(Baylor College of Medicine), Linjie Guo(Baylor College of Medicine), Claudia Martínez-Amador(Baylor College of Medicine), Nisha Ghatwai(Baylor College of Medicine), Purva Rathi(Baylor College of Medicine), Michael S. Wood(Baylor College of Medicine), Yanchuan Li(Baylor College of Medicine), Chunchao Zhang(Baylor College of Medicine), Thorsten Demberg(Baylor College of Medicine), Erica J. Di Pierro(Baylor College of Medicine), Andrew C. Sher(Baylor College of Medicine), Huimin Zhang(Baylor College of Medicine), Birju Mehta(Baylor College of Medicine), Sachin G. Thakkar(Baylor College of Medicine), Bambi Grilley(Baylor College of Medicine), Tao Wang(Baylor College of Medicine), Brian Weiss(Cincinnati Children's Hospital Medical Center), Antonino Montalbano(Immunai (United States)), Meena Subramaniam(Immunai (United States)), Chenling Xu(Immunai (United States)), Chirag Sachar(Immunai (United States)), Daniel K. Wells(Immunai (United States)), Gianpietro Dotti(University of North Carolina at Chapel Hill), Leonid S. Metelitsa(Baylor College of Medicine)
Cited by 184
Abstract
Related Papers
No related papers found
Powered by citation graph analysis